Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines

By Ravenscroft N.   Averani G.   Bartoloni A.   Berti S.   Bigio M.   Carinci V.   Costantino P.   D'Ascenzi S.   Giannozzi A.   Norelli F.   Pennatini C.   Proietti D.   Ceccarini C.   Cescutti P.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2802-2816

Elsevier

Access to resources Recommend Favorite

Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents

By Lees A.   Nelson B.L.   Mond J.J.  

Vaccine, Vol. 14, Iss. 3, 1996-02 ,pp. : 190-198

Elsevier

Access to resources Recommend Favorite

Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccha

By Shafer D.E.   Toll B.   Schuman R.F.   Nelson B.L.   Mond J.J.   Lees A.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1273-1281

Elsevier

Access to resources Recommend Favorite

Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines

By Fattom A.   Cho Y.H.   Chu C.   Fuller S.   Fries L.   Naso R.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 126-133

Elsevier

Access to resources Recommend Favorite

Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle

By Tollersrud T.   Zernichow L.   Andersen S.R.   Kenny K.   Lund A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3896-3903

Elsevier

Access to resources Recommend Favorite